Geert Cauwenbergh

Geert Cauwenbergh is the President and CEO of RXi Pharmaceuticals, USA.

Content by Geert Cauwenbergh:

 Research Field Drug discovery

Believe in RNAi

| Geert Cauwenbergh

The gates for gene and cell therapies are open, and RNAi technology could be a serious contender
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist